{
    "run_label": "test",
    "sim_output": "sim-mrhlog",
    "p_mutational_escape": 0.25,
    "p_each_mutation": 0.1667,
    "num_drugs_to_give_initial": 2,
    "num_drugs_to_give": 2,
    "num_additional_markers": 0,
    "num_targets_per_drug": 2,
    "target_shift_per_drug": 2,
    "num_initial_patients": 500,
    "num_months_initial": 60,
    "num_months_run": 120,
    "belief_update_value": 0.05,
    "use_sigmoid": 0,
    "always_do_best_thing": 0,
    "comments": {
                    "use_sigmoid": "0 for false, 1 for true", 
                    "num_targets_per_drug": "try 2 by default, some values will cause it to fail due to wraparound",
                    "target_shift_per_drug": "shift in the markers array for targets per drug",
                    "p_each_mutation": "probability of each mutation occurring in a tumor",
                    "num_months_initial": "how long the burn in should run",
                    "num_months_run": "how many months to run the actual thing",
                    "drugs": "the markers here get overwritten by the actual sim... ignore them",
                    "always_do_best_thing": "If 0, sample from prob distribution on treatments. If 1, do thing with highest prob"
                },
    "h_global": 1,
    "markers": {
        "MGMT-PROMOTER": {
            "index": 0,
            "exponent": 5
        },
        "HLA-A2": {
            "index": 1,
            "exponent": 4
        },
        "HLA-A1": {
            "index": 2,
            "exponent": 3
        },
        "IDH2": {
            "index": 3,
            "exponent": 2
        },
        "IDH1": {
            "index": 4,
            "exponent": 1
        },
        "EGFR": {
            "index": 5,
            "exponent": 0
        }
    },
    "drugs": {
        "BEVACIZUMAB": {
            "markers": ["EGFR", "IDH1"], 
            "adversity": 1, 
            "index": 0
        },
        "TEMOZOLOMIDE": {
            "markers": ["EGFR", "IDH2"], 
            "adversity": 1, 
            "index": 1
        },
        "CABAZITAXEL": {
            "markers": ["EGFR", "HLA-A1"], 
            "adversity": 1, 
            "index": 2
        },
        "TCAR": {
            "markers": ["EGFR",  "HLA-A2"], 
            "adversity": 1, 
            "index": 3
        },
        "DISATINIB": {
            "markers": ["EGFR", "MGMT-PROMOTER"], 
            "adversity": 1, 
            "index": 4
        },
        "NIVOLUMAB": {
            "markers": ["IDH1", "HLA-A1"], 
            "adversity": 1, 
            "index": 5
        },
        "DOXORUBICIN": {
            "markers": ["IDH1", "HLA-A2"], 
            "adversity": 1, 
            "index": 6
        },
        "DURVALUMAB": {
            "markers": ["IDH1", "MGMT-PROMOTER"], 
            "adversity": 1, 
            "index": 7
        },
        "PEMBROLIZUMAB": {
            "markers": ["IDH2", "HLA-A1"], 
            "adversity": 1, 
            "index": 8
        },
        "VARLILUMAB": {
            "markers": ["IDH2", "MGMT-PROMOTER"], 
            "adversity": 1, 
            "index": 9
        },
        "SORAFENIB": {
            "markers": ["HLA-A1", "MGMT-PROMOTER"], 
            "adversity": 1, 
            "index": 10
        }
    }
}

